Cabbacis Reports First Half 2026 Financial Results and Provides Corporate Update

Cabbacis Reports First Half 2026 Financial Results and Provides Corporate Update

Cabbacis (OTCQB: CABI ), a U.S. federally-licensed tobacco-product manufacturer focused on risk-reduction products being developed under the iBLEND™ and X95™ brand names, today announced that it has filed its Semiannual Report on Form 1-SA for the six-month period ending June 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”).